ResMed reports PTAB invalidates NYU patent infringement claims

ResMed announced that it has secured a victory after the United States Patent Trial and Appeals Board, or PTAB, invalidated the claims New York University, or NYU, asserted against ResMed, based on seven NYU patents. In June 2021, NYU filed a complaint for patent infringement against ResMed in the United States District Court, District of Delaware. NYU’s complaint alleged that the AutoSet and AutoRamp features of ResMed’s AirSense 10 AutoSet flow generators, infringed one or more claims of seven NYU patents. ResMed filed petitions with the PTAB asserting that all the claims asserted against ResMed were invalid. In rulings issued from December 4 to December 7, the PTAB judges, agreeing with ResMed’s arguments, found that all the challenged claims across the seven patents were invalid.